IVF

INVO Fertility, Inc. Common Stock

2.16 USD
+0.08
3.85%
At close May 8, 4:00 PM EDT
Pre-market
2.22
+0.06
2.78%
1 day
3.85%
5 days
21.35%
1 month
11.92%
3 months
-54.33%
6 months
-78.18%
Year to date
-78.57%
1 year
-80.65%
5 years
-99.70%
10 years
-99.70%
 

About: INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body.

Employees: 32

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

2.45% less ownership

Funds ownership: 7.0% [Q3] → 4.55% (-2.45%) [Q4]

15% less capital invested

Capital invested by funds: $194K [Q3] → $165K (-$29.3K) [Q4]

25% less funds holding

Funds holding: 12 [Q3] → 9 (-3) [Q4]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Research analyst outlook

We haven’t received any recent analyst ratings for IVF.

Financial journalist opinion

Charts implemented using Lightweight Charts™